Hi Calamada

Hopefully the doctor will find this research info sufficient to begin trials. I can get hold of more if needed. Copy and Paste to your hearts content!

BYU study shows Colloidal Silver is as good as penicillin
By Lois M. Collins Deseret, News staff writer

Tests of a Colloidal Silver solution have concluded that it provides an alternative to Antibiotics .

Researchers in Brigham Young University's department of microbiology were asked to test the antimicrobial activity of Colloidal Silver . Silver is "colloidal" when it is suspended in small amounts in liquid. Silver in various forms has been used for centuries as an antimicrobial agent. In the 1800s and early 1900s, people put silver coins in their water barrels to kill microbes and make the water potable. A silver nitrate ointment is applied to the eyes of newborn babies to prevent certain eye problems. And silver sulphadiazine is regularly used to treat burn wounds.

Use of Colloidal Silver, once common, faded with the advent of Antibiotics . Recently, though, concerns about overuse of Antibiotics and the development of antibiotic-resistant microbes has lead to a resurgence of silver's popularity.

And with good reason, according to the study, conducted by BYU's David A. Revelli, microbiologist, and Ron W. Leavitt. The study compared Colloidal Silver to five classes of antibiotics: the tetracyclines, fluorinated quinolones (Ofloxacin), the penicillins, the cephalosporins (Cefaperazone) and the macrolides (Erythromycin).

Both the silver and antibiotics were tested on a variety of microorganisms, including streptococcuses, pneumonia, E. coli, salmonella, shigella and others.

According to the study, silver "exhibits an equal or broader spectrum of activity than any one Antibiotic tested." Where each Antibiotic was effective against specific susceptible organisms, silver "is equally effective" against both gram positive and gram negative organisms.

"The data suggests that with the absence of toxicity associated with Colloidal Silver, in general, and the broad spectrum of antimicrobial activity of Colloidal Silver, it may be effectively used as an alternative to antibiotics," Revelli and Leavitt wrote.

Dr. Dianne Farley-Jones, a family practitioner, recommends Colloidal Silver to her patients for external problems. She hasn't used it internally much, though she said it works quite well for ear infections. "With any kind of abrasion or skin problem, it works really well and really fast. And it seems to have an anti-inflammatory effect, though that hasn't been proven."

Colloidal Silver also seems to have an antiviral effect, Farley-Jones said. She's used it at different times but hadn't recommended it until she saw the BYU research data. Now she encourages patients to use it as a nasal rinse for sinus infection or to spray their throats if they feel like they're getting a viral sore throat.


BACTERIA TESTING
Microbiology Department
Brigham Young University

May 13, 1999

Antibacterial Product (The Silver Solution) Testing Results Summary

The following results suggest that Colloidal Silver is a broad spectrum antimicrobial agent – it is able to effectively stop the growth of, and in fact kill, a variety of bacteria.



Colloidal Silver has been tested against the following organisms.

> Staphylococcus aureus (Pneumonia, eye infections, skin infections (boils, impetigo, cellulitis, and post-operative wound infections), toxic shock syndrome, meningitis, food poisoning, osteomyelitis, and many others) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/22/99 BYU Report.
> Shigella boydii (Bacillary dysentery–characterized by severe cramping abdominal pain and bloody diarrhea) inhibited @ 1.25 ppm and killed @ 2.5 ppm. 1/22/99 BYU Report.
> Salmonella arizona (Food poisoning, etc.) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/28/99 BYU Report.
> Salmonella typhimurium (Food poisoning and enteric fever) inhibited and killed at a concentration of 2.5 ppm. 6/7/99 BYU Report.
> E. coli (Food poisoning, urinary tract infections, traveler’s diarrhea, diarrhea in infants, respiratory tract infections, and wound infections) inhibited and killed @ 2.5 ppm. 1/22/99 BYU Report.
> Haemophilus influenzae (Otitis media (ear infection), pneumonia, meningitis, throat and sinus infections (including epiglottitis in children and sinusitis), and suppurative Arthritis in children) inhibited and killed @ 1.25 ppm. 1/22/99 BYU Report.
> Enterobacter aerogenes ( wound infections, urinary tract infections, bacteremia, and meningitis) inhibited and killed at a concentration of 2.5 ppm. 6/7/99 BYU Report.
> Enterobacter cloacae ( causes ilnesses similar to the E. aerogenes) inhibited and killed at a concentration of 5 ppm. 6/7/99 BYU Report.
> Klebsiella pneumoniae (lower respiratory tract infections, nosocomial infections (infections spread in hospitals), urinary tract and wound infections, and bacteremia) inhibited and killed @ 2.5 ppm. 1/28/99 BYU Report.
> Klebsiella oxytoca, (Similar to those infections caused by K. pneumoniae) inhibited and killed at a concentration of 2.5 ppm. 6/7/99 BYU Report.
> Pseudomonas aeruginosa (severe burn and wound infections, keratitis, pneumonia, meningitis, nosocomial infections, urinary tract infections, etc.) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/22/99 BYU Report.
> Streptococcus pneumoniae (pneumonia, meningitis, sinusitis, otitis media (ear infection) inhibited @ 2.5 ppm and killed @ 5 ppm. 4/21/99 BYU Report.
> Streptococcus pyogenes (skin infections, upper respiratory infections (i.e. strep throat) impetigo, hospital-acquired infections, scarlet fever, etc.) inhibited and killed @ 1.25 ppm. 1/22/99 BYU Report.
> Streptococcus faecalis (Urinary tract infections, endocarditis, wound infections, etc.) inhibited @ 2.5 ppm and killed @ 5 ppm. 1/22/99 BYU Report.
> Streptococcus mutans (A major cause dental plaque and tooth decay etc.) inhibited and killed @ 5 ppm. 2/3/99 BYU Report.
> Streptococcus gordonii (Tooth decay, also implicated in infective endocarditis-an infection of the heart valves) inhibited and killed @ 5 ppm. BYU Report 2/12/99.

David A. Revelli
Microbiologist
Brigham Young University


Dr. Ron W. Leavitt, Ph.D.
Professor of Microbiology/Molecular Biology
Brigham Young University

Can Silver Treat AIDS?
by Nancy Robey
[email protected] ; http://www.colloidal-silver.com

Is there a simple, inexpensive treatment for AIDS? Perhaps so. An obscure but crucial discovery was made at the Biochemsitry Unit of Upjohn Laboratories in 1991: "Among a number of metal ions tested, Zn2+ (zinc), Cn2+ (copper), and Ag1+ (silver) were found to be the most effective inhibitors of renin and the HIV protease (data not shown). Kenectic analysis revealed that inhibition of renin by Ag1+ (silver) is basically identical with that seen with Zn2+ (zinc), i.e., concompetitive, first order with respect to the metal." Biochemistry, September 10, 1991.

Further testing at Upjohn, including a clinical trial, revealed that zinc was toxic in effective dosages. This was the first report that silver is a highly effective protease inhibitor. Over the following years, this same discovery would be made several times. The following article is from the Orem Herald of Provo, Utah, February 13, 1992, on page D1:

The small glass vial is filled with clear liquid resembling water. But an Orem resident is convinced it contains the cure for AIDS. "I don't have a doubt in my mind. It's what eats me alive at night," says Daryle Tichy. Suspended in the liquid, which is mostly distilled water, are ultrafine particles of positively charged silver. By researching within several different sciences, Tichy has determined that the solution will kill the AIDS virus without harming the human body.

Tichy, a full time member of the administrative staff at Brigham Young University's physical plant, said he considers himself a searcher, not a researcher. He looks for patterns and answers to problems by crossing the boundaries of different disciplines such as physics and medicine... Tichy said he had the material tested at two different labs; results showed the solution killed a variety of pathogens, including the HIV virus.

A year later, this same discovery was made at the University Medical Center in Geneva, Switzerland: "Metal-binding proteins are important components of retroviruses such as human immunodeficiency virus (HIV). Therefore, metals could be used as antiviral agents...silver is a highly active bactericidal metal with little toxicity for humans. Silver has also been shown to be a potent inhibitor of HIV protease." Biochemical and Biophysical Research Communications, December 30, 1992. Three years later, Temple University in Philadelphia, Pennsylvania, USA, made this same discovery apparently independently: "We tested the ability of biotic silver protein to inhibit human immunodeficiency virus type 1 (HIV-1) replication in the human T cell line, SupT 1, as measured by syncytia formation. We found that pure silver protein inhibited HIV-1 replication in SupT 1 cells as measured by a reduction in the appearance syncytia in cell culture. There appeared to be little if any acute toxicity associated with the dose of biotic silver protein which inhibited HIV-1 replication...These results are very encouraging and suggest additional experiments that could be done..." Earl E. Henderson, Ph.D. Professor.

The following March 20, 1995, Professor Earl E. Henderson released the findings of another experiment at Temple University: "My laboratory has studied the effects of special formulation of biotic silver protein on human immunodeficiency virus Type 1 (HIV-1) survival and on latency reactivation of HIV-1 in the human lymphoblastoid B cell line, M57-3...The results of the...experiment show that exposure of HIV-1 to 1000 ppm of special formulation of silver protein for one hour at 37 degrees Centigrade completely eliminates infectious HIV-1 as measured by syncytia formation on SupT 1 cells..."

This is what an AIDS patient says about silver therapy: "I was infected with HIV through a forced infection in 1991. I tested positive for the HIV antibody November 18, 1991; of course, the same day as my birthday. From that day forward, my life became something totally beyond anything I could have expected...It has been rough, though. HIV has helped me so, so much. The experience has given me access to my own soul again, to a living, breathing relationship with Spirit; regardless, I have literally gone to hell for much of it...While I had plenty of good days, I was getting more and more bad days... "The 106 degree fevers began to return, the intense body pain, the harsh, long-lasting chills... I began to make my own immediate funeral arrangements....and then this voice popped into my head and told me to get the hell on colloidal silver RIGHT NOW! Sure enough, within a week I had begun to gain the weight I had lost back, and in two weeks, I had gone back to mountain climbing. Wow!

I still feel absolutely incredible. I have symptoms of nothing and I am back to my hyperactive self. This new dosing of silver seems to be taking care of my oral thrush problem and is keeping the MAC at bay...I'd like to think I could be cured of this disease...I feel so good that, if I was to start getting sick again and move closer to death, I would be so thankful for this period of absolute health that it would be okay. I do not know how long I am to live, nor do I know how my death will come." T. W.
Colloidal Silver in Medical Literature

AIDS Study
Eight people recover from the AIDS virus in a scientifically documented study. An additional seven AIDS patients recovered as verified by anecdotal reports, as reported by Dr. M. Paul Farber, M.P. N.D., Ph.D., D.C. Author of the "Micro Silver Bullet TM" 4th Edition, November 1996 ISBN 1-87742-00 X Pages XIII & XVI.

Lyme Disease
“Borrelia burgdorferi and hermsti, organisms associated with causing the symptoms of Lyme Disease, were tested at the Department of Health and Human Services, Rocky Mountain Laboratories and Fox Chase Cancer Center, respectively, in 1995; in the Rocky Mountain Labs study, it was demonstrated that no live spirochetes of either borrellia burgdorferi [B310 Orhermsti (HS-1)] survived after 24 hours of exposure to colloidal silver in concentrations of 15 ppm and 150 ppm.” – Department of Health and Human Services, National Institutes of Health, Rocky Mountain Laboratories, January, 13, 1995, Schuan, Tom, Ph.D., Burgdorfer, Willy, Ph.D.

Cancer Research
“Research by Dr. Robert O. Becker, and others indicated that in laboratory tests conducted, Colloidal Silver reverted cancer cells back to normal (not kill them but return them to normal). Other observations were made such as a correlation between silver deficiency and illness or proper immune system functioning, burns, soft tissue and bone repair acceleration, and the formation of cells that appear to be able to repair virtually any part of the body. Reduction of inflammation and the antibacterial, germicidal, astringent, Antibiotic attributes so far observed are yet to be fully understood.” - The Body Electric, Dr. Robert O. Becker ISBN 0688069711 Quill, New York or William Morrow & Company

Infections
C.E.A. MacLeod reports colloidal silver being used with marked success in the following cases: "Septic and follicular tonsillitis, Vincent’s angina, phlyctenular conjunctivitis, gonorrheal conjunctivitis, spring catarrh, impetigo (contagious Acne of face and body), septic ulcer of legs, ringworm, soft sores, suppurative appendicitis after operation (the wounds cleaned rapidly), pustular eczema of scalp and pubes, chronic eczema of meatus of ear with recurrent boils, chronic suppuration in otitis media, and bromidrosis of feet. By injection: gonnorrhoea and chronic cystitis (local), boils,
epididymitis." - Lancet, Feb. 3, 1912 p. 83.

"The germicidal action of certain metals in the colloidal state having been demonstrated, it only remained to apply them to the human subject, and this has been done in a large number of cases with astonishingly successful results. It is not suggested that colloidal metal solutions have no disadvantages, but for internal administration, either orally or hypodermically, they have the advantage of being rapidly fatal to the parasites both bacterial and otherwise without any toxic action on the host. Colloidal silver solution is quite stable even in the presence of salts and the normal constituents of the blood. Its destructive action on toxins is very marked, so that it will protect rabbits from ten times the lethal dose of tetanic (from tetanus) or diphtheric toxin." - Searle, A. B. The Use of Colloids in Health and Disease (Quoting from the British Medical Journal, May 12, 1917 p.83), E.P. Dutton & Company, New York, 1919, p.75
Clifton Mining Company - New Human Study Data Released
ALPINE, UT, Feb. 27 /CNW/ - Clifton Mining Company (Clifton)(OTC:CFTN)
American Biotech Labs (a private company in which Clifton, the largest
shareholder is releasing new human study data on use of the ASAP Solution [Colloidal Silver] in west African hospitals, against a number of human ailments including malaria and a viral infections.

New Human Studies

American Biotech Labs (ABL) has been working in conjunction with four
hospitals in West Africa that have been conducting human studies of the ASAP
product as a antibiotic alternative against human ailments like malaria,
fungal infections, ear infections, measles, septic ulcers and a number of
serious viral problems. This is the second set of human studies released by
the west African hospitals. The new studies found the product effective
against all the above ailments. In conjunction with the human studies, the
country of Ghana has approved the ASAP supplement product as a homeopathic
drug.

Malaria

The past ASAP human malarial studies found the product effective in all
of the cases averaging only five days of treatment to full recovery. This new
study has taken the testing to a new level checking the blood of patients
deemed fully recovered to see if any signs of the parasites remain in the
bloodstream. According to the data in the studies, the patients showed
absolutely no malarial protozoans left in the bloodstream. Over 900 million
people are estimated to have this disease, many in poor countries. Said Keith
Moeller, VP, "Evidence is steadily mounting that we may be able to help
millions of people who are suffering from this disease. It is also exciting to see the first human studies in which the product is being used as a treatment for people who suffer from serious viral infections." Testing of the ASAP product continues in the African hospitals, as well as in numerous other facilities worldwide.

Copies Of The Study

Copies of the second set of the human studies will be released today and
will be made available upon request.

Clifton trades on the U.S. OTC: (CFTN).

Note: Any statements released by Clifton Mining Company that are forward
looking are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Editors and investors are cautioned
that forward looking statements invoke risk and uncertainties that may affect
the company's business prospects and performance. For further information: Dr. Ken Friedman, President at (303) 624-0659, Keith Moeller, Vice President at (801) 756-1414 or see our website at http://www.cliftonmining.com

http://www.newswire.ca/en/releases/archive/February2004/27/c4732.html
CS Research Findings

Since colloidal silver has hardly been considered for the last 50 years, some of the best scientific research was conducted before 1938. A wide range of pathogens and conditions were addressed using silver. The following is a collection of pathogens and conditions I have found documented before 1938 where patients were being successfully treated using silver:


Anthrax Bacilli 2, 3
Appendicitis 3
Axillæ and blind boils of the neck 10
B. Coli 2
B. Coli Communis 7
B. Dysenteria 2
B.Pyocaneus 2
B. Tubercolosis 7
Bacillary Dysentery 4
Bladder Irritation 12
Blepharitis (infection of the eyelids) 13
Boils 10
Bromidrosis in Axille 12
Bromidrosis in Feet 10
Burns and wounds of the cornea 13
Cerebro-spinal Meningitis 3, 9
Chronic Cystitis 10
Chronic Eczema of Anterior Nares 10
Chronic Eczema of metus of ear 10
Colitis 4
Cystitis 8
Dacryocystitis 13
Dermatitis suggestive of toxæmia 4
Diarrhoea (diarrhea) 4
Diptheria 3
Dysentery 3, 6
Ear Affections 5
Enlarged Prostate 12
Epiditymitis 10
Erysipelas 3
Eustachian tubes (potency restored) 8
Follicular Tonsilitis 10
Furunculosis (Hidradenitis Suppurativa) 3
Gonococcus 7
Gonorrhoea 10
Gonorrhoeal Conjunctivitis 10
Gonorrhoeal Opthalimia 13
Gonorrhoeal Prostratic Gleet 11
Hæmorrhoids 12
Hypopyon Ulcer 13
Impetigo 10
Infantile Disease 16
Infected ulcers of the cornea 13
Inflammatory Rheumatism 3
Influenze 11
Interstitial Keratitis 13
Intestinal troubles 6
Lesion Healing 12
Leucorrhoea 6
Menier's Symptoms 6
Nasal Catarrh 5
Nasopharyngeal Catarrh (reduced) 8
Oedematous enlargement of turbinates without true hyperplasia 9
Offensive discharge of chronic suppuration in Otitis Media 10
Ophthalmology 12
Opthalmic practices 5
Para-Typhoid 3
Paramecium (Alternate names for Balantidium coli include Holophrya coli, Leukophrya coli, and Paramecium coli., Balantidiasis) 1
Perineal Eczema 12
Phlegmons 3
Phlyctenular Conjunctivitis 10
Pneumococci 2
Pruritis Ani 12
Puerperal Septicæmia 15
Purulent Opthalmia of infants 13
Pustular Eczema of scalp 10
Pyorrhoea Alveolaris (Riggs disease) 8
Quinsies 6
Rhinitis 9
Ringworm of the body 10
Scarlatina 3
Sepsis 16
Septic Tonsilitis 10
Septic Ulcers of the legs 10
Septicæmia 5, 8
Shingles 6
Soft Sores 10
Spring Catarrh 10
Sprue 6
Staphyloclysin (inhibits) 2
Staphylococcus Pyogenea 7
Staphylococcus Pyogens Albus 2
Staphylococcus Pyogens Aureus 2
Streptococci 7
Subdues inflammation 12
Suppurative Appendicitis (post-op) 10
Tinea Versicolor 10
Tonsilitis 6
Typhoid 3
Typhoid Bacillus 14
Ulcerative Urticaria 4
Urticaria suggestive of toxæmia 12
Valsava's inflammation 8
Vincent's Angina 10
Vorticella 1
Warts 12
Whooping Cough 8

More recent articles have described silver being used to treat the following:

Adenovirus 5, 23
Aspergillus Niger 18
Bacillius Typhosus 21
Bovine Rotavirus 23
Candida Albicans 18, 25
Candida Globata 25
Entamoeba Histolytica (cysts) 24
Escherichia Coli 17, 18, 21
Gardnerella Vaginalis 25
Legionella Pneumophila (Legionaire's Disease) 17
M. Furfur 25
Neisseria Gonorrhea 25
Poliovirus 1 (Sabin strain) 23
Pseudomonas Aeruginosa 17, 18










Salmonella 23
Salmonella Typhi 25
Spore-forming Bacteria 24
Staphylococcus Aureus 17, 25
Streptococcus Fæcalis 17
Streptococcus Pyogenes 25
Vegetative B. Cereus cells 24

The following is a documented list of silver resistant bacteria:

Citrobacter Freundii 20
Enterobacter Cloacæ 20
Enterobacteriaceæ (some strains) 19
Escherichia Coli (some strains) 19
Klebsiella Pneumnoniæ 20
P. Stutzeri (some sträins) 19
Proteus Mirabilis 20
Vegetative B. Cereus Spores 24


Bibiography
1. Bechhold, H. (1919). Colloids in Biology and Medicine, translated by J. G. M. Bullow. D. Van Nostrand Company, New York, p. 367.
2. Ibid., p. 368.
3. Ibid., p. 376.
4. Searle, A. B. (1919). The Use of Colloids in Health and Disease. (Quoting from the British Medical Journal, May 12, 1917). E. P. Dutton and Company: New York, p. 82
5. Ibid., (Quoting from the British Medical Journal, Jan. 15, l(s)17), p. 83.
6. Ibid., (Quoting Sir James Cantlie in the British Medical Journal, Nov. 15, 1913), p. 83.
7. Ibid., (Quoting Henry Crookes), p. 70.
8. Ibid., (Quoting J. Mark Hovell in the British Medical Journal, Dec. 15, 1917), p. 86.
9. Ibid., (Quoting B. Seymour Jones), p. 86.
10.Ibid., (Quoting C.E. A. MacLeod in Lancet, Feb. 3, 1912), p. 83.
11. Ibid., (Quoting J. MacMunn in the British Medical Journal, 1917, I, 685), p. 86.
12. Ibid., (Quoting Sir Malcom Morris in the British Medical Journal, May, 1917), p. 85.
13. Ibid., (Quoting A. Legge Roe in the British Medical Journal, Jan. 16, 1915), p. 83.
14. Ibid., (Quoting W. J. Simpson in Lancet, Dec. 12, 1914), pp. 71-72.
15. Ibid., (Quoting T. H. Anderson Wells in Lancet, Feb. 16, 1918), p. 85.
16. (1931). Index-catalogue of the Library of the Surgeon General's Office United States Army. United States Government Pnnting Office, Washington, v. IX, p. 628.
17. Moyasar, T. Y.; Landeen, L. K.; Messina, M. C.; Kutz, S. M.; Schulze, R.; and Gerba, C. P. (1990). Disinfection of Bacteria in Water Systems by Using Electrolytically Generated Copper, Silver and Reduced Levels of Free Chlorine. Found in Canadian Journal of Microbiology. The National Research Council of Canada: Ottawa, Ont., Canada, pp. 109-116.
18. Simonetti, N.; Simonetti, G.; Bougnol, E; and Scalzo, M. ( 1992). Electrochemical Ag+ for Preservative Use. Article found in Applied and Environmental Microbiology, American Society for Microbiology, Washington, V. 58, 12, pp. 3834-3836.
19. Slawson, R. M.; Van Dyke, M. I.; Lee, H.; and Trevors, J. T. (1992). Germanium and Silver Resistance, Accumulation, and Toxicity in Microorganisms. Article found in Plasmid. Academic Press, Inc., San Diego, v. 27, 1, pp. 73-79.
20. Thurman, R. B. and Gerba, C. P. (1989). The Molecular Mechanisms of Copper and Silver Ion Disinfection of Bacteria and Viruses. A paper presented in the First International Conference on Gold and Silver in Medicine. The Silver Institute, Washington, v. 18, 4, p. 295. 21. Ibid., p. 299.

21. Ibid., p. 299.
22. Ibid., p. 300.
23. Ibid., p. 301.
24. Ibid., p. 302.

25. Larry C. Ford, MD, Department of Obstetrics and Gynecology, UCLA School of Medicine, Center for the Health Sciences, November 1,1988. Letter available from Teamwork Marketing, PO Box 916, San Anselmo CA 94979.
This list, along with the references, should at least help our doctor friends realize that a lot of research has already been done on colloidal silver. At one time it was quite commonly used.
Silver RDA’s

Dr John Hill D.C. in his book “Colloidal Silver, A Literature Review” states this:

“Critics of colloidal silver sometimes state that it has been known to cause organ damage, kidney damage, pulmonary edema, atherosclerosis and death.

“These claims appear to be based on a research study on dogs in which the dogs were deliberately killed by extremely large, lethal doses of silver. At the doses given, any heavy metal and probably many essential minerals like zinc, iron, copper, etc. would have produced death in similar fashion."

And again "We know that dogs died from injections of a type of protein-bound silver in dosages ranging from 500 mg to 1.9 grams of silver depending on the frequency of administration. This was equivalent in silver content to giving a 150 pound adult between 150 litres and 570 litres of 10 ppm colloidal silver, or between 75 and 285 liters of 20 ppm colloidal silver or between 50 and 190 litres of 30 ppm colloidal silver. The 10 gram estimated lethal dose for humans from Goodman and Gillman is equivalent to 1000 liters of 10 ppm colloidal silver." In another case an individual ingested an estimated 124 grams of silver nitrate over a 9-year period. She developed argyria and an assortment of neurological symptoms as well... This report is often used by critics to attribute neurological disorders to silver consumption. They curiously fail to put in perspective the gross difference between the quantities of silver involved."

He also reports:
"The EPA publishes a reference dose (Rfd) for silver which is an estimate of daily exposure to the entire population that is unlikely to be associated with a significant risk of adverse effects over a lifetime. The current Rfd for oral silver exposure is 5 micrograms/kg/day with a critical dose estimated at 14 micrograms/kg/day... Based on this Rfd, a 150 pound adult should not exceed 350 micrograms/day."

He then states that if an average person drinks 2 litres of water a day containing the EPA limit of 0.1 PPM and whose daily diet may contain about 90 micrograms of silver, that would total less than 300 micrograms/day, which means that one could take a dose of 2 tsp. of 5 PPM or 1 tsp. of 10 PPM and still be under the Rfd!! 350 micrograms is equivalent to 70 mls (2oz, 1.4 tsp.) of 5 PPM colloidal silver.

These limits are extremely conservative, and the content of silver in food is almost non-existent these days. One should also weigh up the danger of damage caused by prescription medicine against the results that taking CS produces.